Hyoscine butylbromide
- Generic Name
- Hyoscine butylbromide
- Brand Names
- Buscopan
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30NO4
- CAS Number
- 7182-53-8
- Unique Ingredient Identifier
- 2Z3E1OF81V
- Background
Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it does not directly affect pain, ...
- Indication
Used to treat abdmoninal cramping and pain .
- Associated Conditions
- Gastrointestinal spastic and hypermotility disorders, Infantile Hypertrophic Pyloric Stenosis, Menstrual Distress (Dysmenorrhea), Muscle Spasms, Pain, Primary Dysmenorrhoea, Stiffness of the Urinary Tract, Acute biliary spasm, Acute gastrointestinal spasms, Acute genitourinary spasms, Genitourinary smooth muscle spasm
- Associated Therapies
- Analgesia, Smooth muscle relaxation prior to radiological procedures therapy
France warns of penalties if Opella production goes offshore
Sanofi in exclusive talks with Clayton Dubilier & Rice to sell a 50% stake in Opella, valued at €16 billion. French government demands production, R&D, management, and workforce remain in France, with €70 million investment commitment. Sanctions include €40 million fine for closing facilities and €100,000 per layoff. France to take 2% stake in Opella. CD&R outbid PAI Partners, raising concerns over job security.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath